Inflammatory bowel disease is associated with functional TNF polymorphism affecting OCT1/NF-kappa B interaction

Inflammatory bowel disease is associated with functional TNF polymorphism affecting OCT1/NF-kappa B interaction

Bibliographic Details
Main Authors:	van Heel, D, Udalova, I, De Silva, A, McGovern, D, Kinouchi, Y, Hull, J, Lench, N, Cardon, L, Carey, A, Kwiatkowski, D, Jewell, D
Format:	Journal article
Published:	2002

Similar Items

Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors.
by: van Heel, D, et al.
Published: (2002)

Inflammatory bowel disease is associated with a functional TNF polymorphism that affects an OCT1/NF-KB transcription factor interaction
by: Van Heel, D, et al.
Published: (2002)

Association of accelerated erosive rheumatoid arthritis with a polymorphism that alters NF-kappaB binding to the TNF promoter region.
by: Udalova, I, et al.
Published: (2002)

Interaction of AP-1 with a cluster of NF-kappa B binding elements in the human TNF promoter region.
by: Udalova, I, et al.
Published: (2001)

Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.
by: Udalova, I, et al.
Published: (2000)

Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.
by: McGovern, D, et al.
Published: (2005)

Identification of novel polymorphisms in the beta7 integrin gene: family-based association studies in inflammatory bowel disease.
by: van Heel, D, et al.
Published: (2001)

Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease.
by: Negoro, K, et al.
Published: (2003)

Quantitative prediction of NF-kappa B DNA-protein interactions.
by: Udalova, I, et al.
Published: (2002)

TUCAN (CARD8) genetic variants and inflammatory bowel disease.
by: McGovern, D, et al.
Published: (2006)

Fine mapping of the IBD1 locus did not identify Crohn disease-associated NOD2 variants: implications for complex disease genetics.
by: van Heel, D, et al.
Published: (2002)

A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria.
by: Knight, J, et al.
Published: (1999)

Inflammatory bowel disease: progress toward a gene.
by: van Heel, D, et al.
Published: (2000)

Genetics of inflammatory bowel disease--an update.
by: van Heel, D, et al.
Published: (2001)

The efficacy of methotrexate for maintaining remission in inflammatory bowel disease.
by: Fraser, A, et al.
Published: (2002)

Direct evidence for involvement of NF-kappaB in transcriptional activation of tumor necrosis factor by a spirochetal lipoprotein.
by: Udalova, I, et al.
Published: (2000)

Activation of nuclear factor-kappa B (NF-kappa B)in diarrhoea predominant irritable bowel syndrome
by: O'Sullivan, M, et al.
Published: (2001)

Genetics of inflammatory bowel disease: a reappraisal.
by: Orchard, T, et al.
Published: (2000)

Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes.
by: Udalova, I, et al.
Published: (1998)

Are cytokine gene polymorphisms important in the pathogenesis of inflammatory bowel disease?
by: Satsangi, J, et al.
Published: (1996)

Rac mediates TNF-induced cytokine production via modulation of NF-kappaB.
by: Williams, L, et al.
Published: (2008)

Comparing the fine specificity of DNA binding by NF-kappaB p50 and p52 using principal coordinates analysis.
by: Nijnik, A, et al.
Published: (2003)

Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.
by: Koss, K, et al.
Published: (2000)

The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants.
by: van Heel, D, et al.
Published: (2003)

NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.
by: Smith, C, et al.
Published: (2001)

Detecting and modulating the NF-kB activity in human immune cells: generation of human cell lines with altered levels of NF-kappaB.
by: Goh, F, et al.
Published: (2009)

Salicylates for inflammatory bowel disease.
by: Travis, S, et al.
Published: (1994)

Crohn's disease: genetic susceptibility, bacteria, and innate immunity.
by: Van Heel, D, et al.
Published: (2001)

Immunology of inflammatory bowel disease--an update.
by: Jewell, D
Published: (1995)

Immunology of inflammatory bowel disease.
by: Jewell, D, et al.
Published: (1985)

Immunology of inflammatory bowel disease.
by: Hodgson, H, et al.
Published: (1987)

The immunology of inflammatory bowel disease.
by: Lowes, JR, et al.
Published: (1990)

Mechanism of inactivation of NF-kappa B by a viral homologue of I kappa b alpha. Signal-induced release of i kappa b alpha results in binding of the viral homologue to NF-kappa B.
by: Tait, S, et al.
Published: (2000)

Atopy in inflammatory bowel disease.
by: Mee, A, et al.
Published: (1979)

Cytokines and inflammatory bowel disease.
by: Radford-Smith, G, et al.
Published: (1996)

Evolution of a polymorphic regulatory element in interferon-gamma through transposition and mutation.
by: Ackerman, H, et al.
Published: (2002)

NOD2 (CARD15), the first susceptibility gene for Crohn's disease.
by: McGovern, D, et al.
Published: (2001)

The genetics of inflammatory bowel disease.
by: Satsangi, J, et al.
Published: (1997)

Cytokine production in inflammatory bowel disease.
by: Satsangi, J, et al.
Published: (1994)

Macrophage activity in inflammatory bowel disease.
by: Mahida, Y, et al.
Published: (1990)